Alternative operation mode for an implantable medical device based upon lead condition
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61N-001/32
A61N-001/05
A61N-001/36
A61N-001/08
출원번호
US-0925746
(2007-10-26)
등록번호
US-8942798
(2015-01-27)
발명자
/ 주소
Armstrong, Randolph K.
Rodriguez, Albert A.
Maschino, Steven E.
출원인 / 주소
Cyberonics, Inc.
대리인 / 주소
Cyberonics, Inc.
인용정보
피인용 횟수 :
2인용 특허 :
192
초록▼
A method, apparatus, and system for determining an adverse operational condition associated with a lead assembly in an implantable medical device used for providing a therapeutic electrical signal to a cranial nerve. A first impedance associated with the lead assembly configured to provide the thera
A method, apparatus, and system for determining an adverse operational condition associated with a lead assembly in an implantable medical device used for providing a therapeutic electrical signal to a cranial nerve. A first impedance associated with the lead assembly configured to provide the therapeutic electrical signal to a cranial nerve is detected. A determination is made as to whether the first impedance is outside a first predetermined range. A second impedance is detected. The detection of the second impedance is performed within a predetermined period of time from the time of the detection of the first impedance. A determination is made as to whether the second impedance is outside a second predetermined range. If the first impedance is outside the first range and the second impedance is outside the second range, the implantable medical device is prevented from providing the therapeutic electrical signal.
대표청구항▼
1. A method comprising: determining first impedance associated with a lead assembly of an implantable medical device;determining whether the first impedance is within an acceptable range;determining at least one parameter associated with the lead assembly when the first impedance is out of the accep
1. A method comprising: determining first impedance associated with a lead assembly of an implantable medical device;determining whether the first impedance is within an acceptable range;determining at least one parameter associated with the lead assembly when the first impedance is out of the acceptable range;analyzing the at least one parameter to determine whether a lead assembly problem is intermittent;performing a pre-stimulation check prior to delivery of a therapeutic electrical signal when the lead assembly problem is intermittent;delivering the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is functional; anddelaying delivery of the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is not functional. 2. The method of claim 1, wherein determining the first impedance comprises: providing a controlled current signal through a first terminal and a second terminal associated with the lead assembly;measuring a voltage across the first and second terminals during at least a portion of a time period during which the controlled current signal is provided through the first and second terminals to determine a measured voltage; anddetermining the first impedance based upon the controlled current signal and the measured voltage. 3. The method of claim 2, wherein the controlled current signal is a test pulse that has a small magnitude compared to the therapeutic electrical signal. 4. The method of claim 2, wherein an impedance value of a first lead is subtracted from an impedance determined from the controlled current signal and the measured voltage to generate the first impedance. 5. The method of claim 1, further comprising preventing the implantable medical device from providing the therapeutic electrical signal when the lead assembly problem is determined to be a significant problem. 6. The method of claim 1, wherein the implantable medical device enters a secondary mode from a normal mode of operation when the lead assembly problem is determined to exist. 7. The method of claim 6, wherein, when the implantable medical device is in the secondary mode, the method further comprises: shutting down an operation of the implantable medical device;altering a dosage of the therapeutic electrical signal;disabling an electrode associated with the lead assembly;or combinations thereof. 8. The method of claim 7, wherein altering the dosage comprises reducing a number of pulses in the therapeutic electrical signal, increasing a time period of off time, reducing current amplitude of the therapeutic electrical signal, reducing a frequency of a pulse train of the therapeutic electrical signal, decreasing a pulse width of the therapeutic electrical signal, or combinations thereof. 9. The method of claim 1, further comprising performing a notification process when the lead assembly problem is determined to exist. 10. The method of claim 9, wherein the notification process comprises performing a patient notification process, a health-care professional notification process, a manufacturer notification process, or combinations thereof. 11. The method of claim 9, wherein the notification process comprises providing an audible notification, a tactile notification, a vibration notification, an electrical notification, an electronic notification, or combinations thereof. 12. A method comprising: determining via a controller of an implantable medical device whether an impedance associated with a lead assembly of the implantable medical device is within an accepted range;performing at least one test to generate data associated with the lead assembly when the impedance is not within the accepted range;classifying a type of problem associated with the lead assembly based on the data;performing a first remedial action when the type of the problem is an intermittent problem, wherein the first remedial action includes: performing a pre-stimulation check prior to delivery of a therapeutic electrical signal;delivering the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is functional; anddelaying delivery of the therapeutic electrical signal when the pre-stimulation check indicates that the lead assembly is not functional; andperforming a second remedial action when the type of the problem is a second type, wherein the first remedial action is different than the second remedial action. 13. The method of claim 12, wherein classifying the type of the problem comprises determining whether the problem is the intermittent problem, a severe problem, a significant problem, or combinations thereof. 14. The method of claim 12, wherein the second remedial action comprises stopping application of therapeutic electrical signals by the implantable medical device, modifying at least one electrical parameter of the therapeutic electrical signals provided by the implantable medical device, running a pre-stimulation diagnostic check prior to delivering the therapeutic electrical signal, disabling an electrode associated with the lead assembly, or combinations thereof. 15. The method of claim 12, wherein the at least one test comprises a current output test, a lead impedance test, a power output test, an energy output test, a charge imbalance test, a compensation voltage test, or combinations thereof. 16. A method comprising: monitoring a lead condition of a lead assembly of an implantable medical device configured to provide therapeutic electrical signals;receiving data that indicates a lead condition problem;performing a lead condition analysis to classify a type of the lead condition problem;preventing the implantable medical device from providing the therapeutic electrical signals when the type of the lead condition problem is a severe problem; andimplementing a secondary operation mode of the implantable medical device when the type of the lead condition problem is other than the severe problem by: performing a pre-stimulation check regimen prior to providing a therapeutic electrical signal of the therapeutic electrical signals when the type is an intermittent problem; andimplementing one of an alternate dosage of the therapeutic electrical signals applied by the implantable medical device or a change in an electrode configuration when the type is neither the intermittent problem nor the severe problem. 17. The method of claim 16, further comprising providing a notification to a patient, a health-care professional, a manufacturer of at least a portion of the implantable medical device, a manufacturer of at least a portion of the lead assembly in response to detecting the lead condition problem, or combinations thereof. 18. The method of claim 16, wherein the lead condition analysis comprises: detecting a lead impedance;determining whether the lead impedance is outside a predetermined range;performing a diagnostic function in response to a determination that the lead impedance is outside the predetermined range to generate diagnostic data; andperforming a statistical analysis of the diagnostic data. 19. The method of claim 16, wherein the implantable medical device is configured to provide cranial nerve stimulation. 20. The method of claim 16, wherein the alternate dosage comprises a reduction in a number of pulses, an increase in a period of off time, a reduction in current amplitude, a reduction in a frequency of a pulse train of the therapeutic electrical signal of the therapeutic electrical signals, a decrease in pulse width, or combinations thereof. 21. A non-transitory computer readable medium comprising instructions, that when executed by a processor, cause the processor to perform operations including: performing at least one test to generate data associated with a lead assembly of an implantable medical device when an impedance associated with the lead assembly is outside of an accepted range;detecting that a problem is associated with the lead assembly based on the at least one test;classifying a type of the problem associated with the lead assembly;implementing a first remedial action when the type of the problem is a first type by: performing a pre-stimulation check before initiation of a therapeutic electrical signal from the implantable medical device to a patient when the type of the problem is an intermittent problem;initiating the therapeutic electrical signal when the pre-stimulation check indicates that there is no lead assembly problem; anddelaying the therapeutic electrical signal when the pre-stimulation check indicates existence of the lead assembly problem; andimplementing a second remedial action when the type of the problem is a second type, wherein the first remedial action is different than the second remedial action. 22. The non-transitory computer readable medium of claim 21, wherein the at least one test comprises a current output test, a lead impedance test, a power output test, an energy output test, a charge imbalance test, a compensation voltage test, or combinations thereof. 23. The non-transitory computer readable medium of claim 21, wherein operations further include, in response to detecting the problem, providing a notification to the patient, a health-care professional, a manufacturer of at least a portion of the implantable device, a manufacturer of at least a portion of the lead assembly, or combinations thereof. 24. The non-transitory computer readable medium of claim 21, wherein the operations implementing the first remedial action include preventing application of the therapeutic electrical signal from the implantable medical device to the patient when the type of the problem is a severe problem.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (192)
Baker ; Jr. Ross G. (Houston TX) Terry ; Jr. Reese S. (Houston TX) Adkins Alan (Angleton TX), Activation techniques for implantable medical device.
Crish Timothy J. (North Olmsted OH) Sweeney James D. (Cleveland Heights OH) Mortimer J. Thomas (Cleveland Heights OH), Antidromic pulse generating wave form for collision blocking.
Boveja Birinder Bob, Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator.
Ungar Ira J. (Shaker Heights OH) Mortimer J. Thomas (Cleveland Heights OH), Asymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking.
Adkins Robert A. ; O'Donovan Cormac A. ; Terry ; Jr. Reese S., Automatic activation of a neurostimulator device using a detection algorithm based on cardiac activity.
Hafelfinger Werner (Valencia CA) Sholder Jason A. (Northridge CA) King Murray P. (Simi Valley CA) Duncan James L. (Alpharetta GA), Automatic electrode configuration of an implantable pacemaker.
Wahlstrand John D. (Shoreview MN) Baxter Daniel J. (St. Paul MN) Ecker R. Michael (Anoka MN) Greeninger Daniel R. (Coon Rapids MN) Yerich Charles G. (Fridley MN), Automatic lead recognition for implantable medical device.
Daly Christopher,AUX ; Nygard Tony Mikeal,AUX ; Carter Paul Michael,AUX ; Money David Kerry,AUX ; Patrick James Finlay,AUX ; Olufson Christopher Mark,AUX, Cochlear implant system with soft turn on electrodes.
Terry ; Jr. Reese F. (Houston TX) Stanislaw Henry (Blairstown NJ) Varrichio Anthony J. (Flanders NJ) Winstrom William L. (Andover NJ), Constant current sources with programmable voltage source.
Miller Leslie S. (Saugus CA) Helland John R. (Santa Clarita CA), Electrically programmable polarity connector for an implantable body tissue stimulator.
Byers Charles L. (Canyon Country CA) Schulman Joseph H. (Granada Hills CA) Whitmoyer David I. (Los Angeles CA), Electrode array for use in connection with a living body and method of manufacture.
Steinhaus Bruce M. (Parker CO) Vance Fred I. (Parker CO) Curtis Anne (Gansville FL) Koestner Ken (Englewood CO), Heart rejection monitoring apparatus and method.
Livingston John H. (Coral Gables FL) Yomtov Barry M. (Pembroke Pines FL), Implantable cardiac pacer having dual frequency programming and bipolar/unipolar lead programmability.
Ideker Raymond E. (Durham NC) Fine Michael J. (Lake Jackson TX) Baker ; Jr. Ross G. (Houston TX) Calfee Richard V. (Houston TX), Implantable defibrillation electrodes.
Jorgenson David J. ; Starkson Ross O. ; McVenes Rick D. ; Trautmann Charles D. ; Wahlstrand John D. ; Peck Bradley C., Implantable lead functional status monitor and method.
Jorgenson, David J.; Starkson, Ross O.; McVenes, Rick D.; Trautmann, Charles D.; Wahlstrand, John D.; Peck, Bradley C., Implantable lead functional status monitor and method.
Baker ; Jr. Ross G. (Houston TX) Terry ; Jr. Reese S. (Houston TX), Implantable medical device with dummy load for pre-implant testing in sterile package and facilitating electrical lead c.
Meadows, Paul M.; Mann, Carla M.; Tsukamoto, Hisashi; Chen, Joey, Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries.
Schulman Joseph H. ; Mann Alfred E. ; Gord John C. ; Lebel Ronald J., Implantable stimulator that prevents DC current flow without the use of discrete output coupling capacitors.
Stanislaw Henry (Blairstown NJ), Implanted apparatus having micro processor controlled current and voltage sources with reduced voltage levels when not p.
Wahlstrand,Carl D.; Hoegh,Thomas Barry; Hrdlicka,Gregory A.; Cross, Jr.,Thomas E.; Olsen,James M., Lead electrode for use in an MRI-safe implantable medical device.
Stroetmann Brigitte (Uttenreuth DEX) Mund Konrad (Uttenreuth DEX) Kallert Siegfried (Erlangen DEX), Method and apparatus for detecting a state of imminent cardiac arrhythmia in response to a nerve signal from the autonom.
Boveja, Birinder R.; Widhany, Angely, Method and apparatus for electrical stimulation adjunct (add-on) treatment of urinary incontinence and urological disorders using an external stimulator.
Reinke,James D.; Wilkinson,Jeffrey D.; Kalin,Ron; Foerster,Laurie D.; Zeijlemaker,Volkert A., Method and apparatus for shunting induced currents in an electrical lead.
Zeijlemaker, Volkert A.; Kalin, Ron; Hrdlicka, Gregory A.; Cho, Yong Kyun; Reinke, James D.; Foerster, Laurie D., Method and apparatus for shunting induced currents in an electrical lead.
Hansen Daniel L. (Aurora CO) Ujhazy Anthony J. (Denver CO), Method and apparatus for testing compatibility of lead polarity and polarity programming of a cardiac stimulator.
Geddes Leslie A. (West Lafayette IN) Elabbady Tarek (Kirkland WA) Schoenlein William E. (Lafayette IN) Waninger Matthew (Frankfort IN) Bourland Joe D. (West Lafayette IN), Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation.
Geddes Leslie A. ; Elabbady Tarek ; Schoenlein William E. ; Waninger Matthew ; Bourland Joe D., Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation.
Geddes Leslie A. (West Lafayette IN) Bourland Joe D. (West Lafayette IN) Terry Reese S. (Freeport TX), Method of and apparatus for automatically detecting and treating ventricular fibrillation.
Naritoku, Dean K.; Jensen, Robert A.; Browning, Ronald A.; Clark, Kevin B.; Smith, Douglas C.; Terry, Jr., Reese S., Methods for improving learning or memory by vagus nerve stimulation.
Dean K. Naritoku ; Robert A. Jensen ; Ronald A. Browning ; Kevin B. Clark ; Douglas C. Smith ; Reese S. Terry, Jr., Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation.
Naritoku Dean K. ; Jensen Robert A. ; Browning Ronald A. ; Clark Kevin B. ; Smith Douglas C. ; Terry ; Jr. Reese S., Methods of treating traumatic brain injury by vagus nerve stimulation.
Steinhaus Bruce M. (Parker) Nappholz Tibor A. (Englewood) Nolan James A. (Conifer) Morris Robert A. (Palmer Lake CO), Minute volume rate-responsive pacemaker employing impedance sensing on a unipolar lead.
Katz Samuel M. (Los Angeles CA) Schloss Harold C. (Los Angeles CA), Periodic electrical lead intergrity testing system and method for implantable cardiac stimulating devices.
Varrichio Anthony J. (Flanders NJ) Winstrom William L. (Andover NJ) Stanislaw Henry (Blairstown NJ), Simultaneous radio frequency and magnetic field microprocessor reset circuit.
Morgan Wayne A. (Granada Hills CA) Mann Brian M. (Beverly Hills CA), System and method for measuring and storing parametric data pertaining to operating characteristics of an implantable me.
Dorfmeister Josef ; Frei Mark ; Lerner David ; Osorio Ivan ; Ralston John, System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain o.
Terry ; Jr. Reese S. (Houston TX) Wernicke Joachim F. (League City TX) Baker ; Jr. Ross G. (Houston TX), Therapeutic treatment of migraine symptoms by stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX), Treatment of eating disorders by nerve stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX), Treatment of eating disorders by nerve stimulation.
Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX) Marquette Andre (Stamford CT), Treatment of motility disorders by nerve stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Zabara Jacob (Philadelphia PA), Treatment of neuropsychiatric disorders by nerve stimulation.
Wernicke Joachim F. (League City TX) Terry ; Jr. Reese S. (Houston TX) Baker ; Jr. Ross G. (Houston TX), Treatment of patients in coma by nerve stimulation.
Osorio,Ivan; Bhavaraju,Naresh C., Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes.
Schulman Joseph H. (Santa Clarita CA) Gord John C. (Venice CA) Strojnik Primoz (Granada Hills CA) Whitmoyer David I. (Los Angeles CA) Wolfe James H. (Canyon Country CA), Voltage/current control system for a human tissue stimulator.
Yuuchi Takahiro (Hyogo JPX) Tsuchida Yasuyuki (Hyogo JPX) Fujiwara Masakatsu (Kasai JPX), Wireless low-frequency medical treatment device with pulse interruption based upon electrode contact with the body.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.